Asthma Trial, Recruiting NCT04331353 Sponsor: Tulane University Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT04331353
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children between 5 and 17 years old who have asthma that is not well controlled
  • Children who have had at least one overnight hospital stay for asthma in the past six months, OR at least two unplanned clinic or emergency department visits for asthma in the past 12 months
  • Children who are either taking a long-term asthma control medication, OR have had asthma symptoms on 3 or more days per week over the past 2 weeks, OR have had nighttime asthma symptoms at least 3 times in the past month
  • Homes where cockroaches are present, shown either by catching at least one cockroach in a 3-day trapping period or by a staff member visually confirming cockroaches
  • Children who sleep in the home being studied at least 4 nights per week on average
  • A parent or caregiver who can speak English or Spanish

Who may not be able to join:

  • Children with other serious or ongoing illnesses, including long-term breathing infections that need daily medication
  • Children with heart disease that requires daily medication (though high blood pressure alone does not automatically disqualify a child — confirm with trial site)
  • Children currently taking a type of medication called a beta-blocker
  • Children who currently smoke
  • Children who are currently receiving allergy immunotherapy (allergy shots or similar treatments)
  • Families who are planning to move within the 12-month follow-up period of the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Felicia Rabito, PhD, Tulane University School of Public Health and Tropical Medicine

Phone: 5049882386

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tulane University
Registry
ClinicalTrials.gov
Start date
15 November 2020
Est. completion
30 April 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Maximum number of symptom days in the previous two weeks; Number of participants with an asthma related hospitalization, unscheduled clinic or emergency room visit for asthma in the previous month; Level of Asthma control

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov